![Werner Föller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Werner Föller is currently the Vice President & General Manager at Shire Deutschland GmbH.
Previously, he held the position of Member-Management Board at Shire Orphan Therapies GmbH and General Manager at Shire Deutschland Investments GmbH.
Postes actifs de Werner Föller
Sociétés | Poste | Début |
---|---|---|
Shire Deutschland GmbH
![]() Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Corporate Officer/Principal | 28/05/2010 |
Anciens postes connus de Werner Föller
Sociétés | Poste | Fin |
---|---|---|
Shire Orphan Therapies GmbH
![]() Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 15/08/2017 |
Shire Deutschland Investments GmbH
![]() Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff. | President | 28/05/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Shire Orphan Therapies GmbH
![]() Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
Shire Deutschland Investments GmbH
![]() Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff. | Health Technology |
Shire Deutschland GmbH
![]() Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Health Technology |